AOD9604 is a synthetic truncated peptide fragment derived from human growth hormone, designed for lipid metabolism and fat breakdown related preclinical research. It targets adipose tissue to stimulate lipolysis while minimizing many growth hormone-associated side effects observed in research models. This peptide regulates fat cell metabolism, promotes the breakdown of stored triglycerides and inhibits lipogenesis, making it a popular research compound for obesity, fat mass regulation and metabolic disorder laboratory studies.

Produced via solid-phase peptide synthesis and multi-stage reversed-phase HPLC purification, the product efficiently eliminates truncated peptide fragments, oxidative impurities and residual organic solvents. Each batch is accompanied by complete COA documents, including HPLC purity analysis, MS molecular weight verification, moisture test, residual solvent assay, endotoxin detection and microbial limit examination to maintain stable batch-to-batch quality. The lyophilized powder greatly slows peptide hydrolysis and degradation, delivering excellent stability for international shipping and long-term storage. Suitable research applications include in vitro adipocyte metabolism assays, lipid signal pathway exploration, in vivo animal fat metabolism model testing and peptide stability assessment.